Correction: Ten steps the federal government should take now to reverse the opioid addiction epidemic (JAMA - Journal of the American Medical Association (2017) 318:16 (1537-1538) DOI: 10.1001/jama.2017.14567);Ten steps the federal government should take now to reverse the opioid addiction epidemic

JAMA - Journal of the American Medical Association

Volumn 318, Issue 16, 2017, Pages 1537-1538

  Kolodny, Andrew ^a   Frieden, Thomas R ^b  

^a BRANDEIS UNIVERSITY   (United States)

^b Resolve   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT; OPIATE AGONIST;

ANALGESIA; DRUG CONTROL; DRUG DEPENDENCE TREATMENT; DRUG FATALITY; DRUG INDICATION; DRUG MARKETING; DRUG MISUSE; DRUG OVERDOSE; EARLY DIAGNOSIS; EPIDEMIC; GOVERNMENT; HARM REDUCTION; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH EDUCATION; HEALTH HAZARD; HEALTH INSURANCE; LIFESTYLE MODIFICATION; NOTE; OPIATE ADDICTION; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; WITHDRAWAL SYNDROME; DRUG LABELING; EPIDEMICS; HUMAN; INSURANCE; LEGISLATION AND JURISPRUDENCE; MARKETING; OPIOID-RELATED DISORDERS; UNITED STATES;

ANALGESICS, OPIOID; DRUG LABELING; DRUG OVERDOSE; EPIDEMICS; FEDERAL GOVERNMENT; HARM REDUCTION; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; MARKETING; OPIOID-RELATED DISORDERS; UNITED STATES;

EID: 85032643414     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2019.14523     Document Type: Erratum

References (8)

1. Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Ann Intern Med. 2017;167(5): 293-301.
2. Gostin LO, Hodge JG Jr, Noe SA. Reframing the opioid epidemic as a national emergency [published online August 23, 2017]. JAMA. doi:10.1001/jama.2017.13358
3. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315(15):1624-1645.
4. Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use-United States, 2006-2015. MMWRMorb Mortal Wkly Rep. 2017;66(10):265-269.
5. Hill MV, McMahon ML, Stucke RS, Barth RJ Jr. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg. 2017;265(4):709-714.
6. Jha P, Chaloupka FJ, Moore J, et al. Tobacco addiction. In: Jamison DT, Breman JG, Measham AR, et al, eds. Disease Control Priorities in Developing Countries. 2nd ed. New York, NY: Oxford University Press, World Bank; 2006:869-885.
7. Lantz PM. Youth smoking prevention policy: Lessons learned and continuing challenges. In: Bonnie RJ, O'Connell ME, eds. Reducing Underage Drinking: A Collective Responsibility. Washington, DC: National Academies Press; 2004:716-742.
8. Auriacombe M, Fatséas M, Dubernet J, Daulouède JP, Tignol J. French field experience with buprenorphine. Am J Addict. 2004;13(suppl 1): S17-S28.